PodParley PodParley
PodParley
ESR1 Mutation Testing in Breast Cancer: Setting the Standard for Personalized Oncology? episode artwork

EPISODE · Nov 4, 2025 · 24 MIN

ESR1 Mutation Testing in Breast Cancer: Setting the Standard for Personalized Oncology?

from Keeping Current CME

Is your patient progressing on an aromatase inhibitor (AI)? Fine-tune ddPCR/NGS testing to detect resistance and optimize oral selective estrogen receptor degrader (SERD) success. Credit available for this activity expires: 11/04/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/esr1-mutation-testing-breast-cancer-setting-standard-2025a1000u0f?ecd=bdc_podcast_libsyn_mscpedu

Episode metadata supplied by the publisher feed · Published Nov 4, 2025

Embed this episode

NOW PLAYING

ESR1 Mutation Testing in Breast Cancer: Setting the Standard for Personalized Oncology?

0:00 24:37

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Keeping Current CME?

This episode is 24 minutes long.

When was this Keeping Current CME episode published?

This episode was published on November 4, 2025.

Can I download this Keeping Current CME episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!